Evaluating associations between the benefits and risks of drug therapy in type 2 diabetes: a joint modeling approach (2018)
Attributed to:
MICA: MRC APBI STratification and Extreme Response Mechanism IN Diabetes - MASTERMIND
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2147/clep.s179555
PubMed Identifier: 30588118
Publication URI: http://europepmc.org/abstract/MED/30588118
Type: Journal Article/Review
Parent Publication: Clinical Epidemiology
ISSN: 1179-1349